Novel Inflammatory Biomarkers in Cardiovascular Therapeutics

被引：1

作者：

Tsigkou, Vicky ^{[1
]}

Siasos, Gerasimos ^{[1
]}

Oikonomou, Evangelos ^{[1
]}

Zaromitidou, Marina ^{[1
]}

Latsios, George ^{[1
]}

Vavuranakis, Manolis ^{[1
]}

Deftereos, Spyridon ^{[1
]}

Cleman, Michael W. ^{[1
]}

Kokkou, Eleni ^{[1
]}

Limberi, Maria ^{[1
]}

Dimitropoulos, Stathis ^{[1
]}

Zografos, Thodoris ^{[1
]}

Marinaki, Smaragdi ^{[1
]}

Stefanadis, Christodoulos ^{[1
,2
]}

Tousoulis, Dimitris ^{[1
]}

机构：

[1] Univ Athens, Sch Med, Hippokrat Hosp, Dept Cardiol 1, GR-11527 Athens, Greece

[2] Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA USA

来源：

CURRENT MEDICINAL CHEMISTRY | 2015年 / 22卷 / 23期

关键词：

Atherosclerosis; biomarkers; cardiovascular diseases; coronary artery disease; heart failure; hypertension; inflammation; peripheral artery disease; stroke; C-REACTIVE PROTEIN; PERIPHERAL ARTERIAL-DISEASE; NECROSIS-FACTOR-ALPHA; ANKLE-BRACHIAL INDEX; ACUTE MYOCARDIAL-INFARCTION; SOLUBLE ADHESION MOLECULES; BRAIN NATRIURETIC PEPTIDE; HEART-FAILURE; ATRIAL-FIBRILLATION; OXIDATIVE STRESS;

D O I：

10.2174/0929867322666150429110124

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Inflammation has been established as an important determinant of cardiovascular disease progression. Currently, clinical examination, laboratory and imaging tests are invaluable for the diagnosis, prognosis and disease monitoring. Novel inflammatory biomarkers are also used to better restratify patients in risk groups but their potential to guide treatment decisions and management of patients has not been extensively evaluated. Therefore, in this review article we present the most recent data concerning the use of inflammatory biomarkers in cardiovascular therapeutics.

引用

页码：2773 / 2785

页数：13

共 50 条

[1] Inflammatory biomarkers for predicting cardiovascular disease
Stoner, Lee
Lucero, Adam A.
Palmer, Barry R.
Jones, Lynnette M.
Young, Joanna M.
Faulkner, James
CLINICAL BIOCHEMISTRY, 2013, 46 (15) : 1353 - 1371
[2] Inflammatory Burden and Immunomodulative Therapeutics of Cardiovascular Diseases
Kao, Ting-Wei
Huang, Chin-Chou
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (02)
[3] Five-Year Changes in Inflammatory, Metabolic, and Oxidative Biomarkers and 10-Year Cardiovascular Disease Incidence: The REGICOR Cohort Study
Camps-Vilaro, Anna
Subirana, Isaac
Ramos, Rafel
Cainzos-Achirica, Miguel
Tizon-Marcos, Helena
Fito, Montse
Degano, Irene R.
Marrugat, Jaume
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (09)
[4] Circular RNAs as Novel Biomarkers for Cardiovascular Diseases
Zhou, Qiulian
Zhang, Zhongrong
Bei, Yihua
Li, Guoping
Wang, Tianhui
CIRCULAR RNAS: BIOGENESIS AND FUNCTIONS, 2018, 1087 : 159 - 170
[5] Inflammatory Biomarkers and Therapeutic Targets in Heart Failure
Papadimitriou, Lampros
Kalogeropoulos, Andreas P.
CURRENT MEDICINAL CHEMISTRY, 2015, 22 (23) : 2716 - 2726
[6] Novel Therapeutics and Upcoming Clinical Trials Targeting Inflammation in Cardiovascular Diseases
Potere, Nicola
Bonaventura, Aldo
Abbate, Antonio
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2024, 44 (12) : 2371 - 2395
[7] Novel cardiovascular biomarkers in patients with cardiovascular diseases undergoing intensive physical exercise
Mirna, Moritz
Lichtenauer, Michael
Wernly, Bernhard
Paar, Vera
Jung, Christian
Kretzschmar, Daniel
Uhlemann, Madlen
Franz, Marcus
Hoppe, Uta C.
Schulze, P. Christian
Hilberg, Thomas
Adams, Volker
Sponder, Michael
Moebius-Winkler, Sven
PANMINERVA MEDICA, 2020, 62 (03) : 135 - 142
[8] BIOMARKERS FOR CARDIOVASCULAR DISEASE - SNAPSHOT
Gajdosik, Z.
Castaner, R.
Dulsat, C.
DRUGS OF THE FUTURE, 2013, 38 (12) : 845 - 849
[9] Multifaceted role of cardiovascular biomarkers
Saheera, Sherin
INDIAN HEART JOURNAL, 2023, 75 (02) : 91 - 97
[10] Epigenetic Biomarkers in Cardiovascular Diseases
Soler-Botija, Carolina
Galvez-Monton, Carolina
Bayes-Genis, Antoni
FRONTIERS IN GENETICS, 2019, 10

← 1 2 3 4 5 →